curasan Gains CE Mark for Spinevisc Hyaluronic Acid

curasan is launching Spinevisc® hyaluronic acid (HA) for the treatment of facet joint arthrosis.

Spinevisc will allow the company to address new target customer groups such as neuroradiologists and interventional pain therapists, as well as spine surgeons.

Other HA-based products from curasan include Curavisc for the treatment of arthritic...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us